BriaCell Therapeutics Stock Quote BCTX - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.99

Bid

0.99

Ask

1.00

Volume

2,543

0.00 Day's Range 0.00

0.4641 52 Week Range 6.0994

Market Cap

18.201M

Previous Close

0.9842

Open

Last Trade

800

0.99

(formt)

Last Trade Time

07:04:39

Financial Volume

VWAP

Average Volume (3m)

5,095,658

Shares Outstanding

18,384,661

Dividend Yield

PE Ratio

-9.60

Earnings Per Share (EPS)

-1.1

Revenue

Net Profit

-20.3M

BriaCell Therapeutics Corp. is a clinical stage immuno-oncology company that is developing an entirely new class of targeted immunotherapies to transform cancer care. Bria-IMT(TM), BriaCell's lead candidate, was awarded Fast Track status by FDA and is being evaluated in a pivotal Phase 3 combination... BriaCell Therapeutics Corp. is a clinical stage immuno-oncology company that is developing an entirely new class of targeted immunotherapies to transform cancer care. Bria-IMT(TM), BriaCell's lead candidate, was awarded Fast Track status by FDA and is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC). MBC is breast cancer that has spread to other tissues. Bria-IMT(TM) is a targeted cell-based immunotherapy. Additionally, BriaCell is developing, Bria-OTS(TM), a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical study initially targeting breast cancer, with extension to prostate cancer, and other cancers. Show more

Sector

Aircraft

Industry

Business Services, Nec

Website

www.briacell.com

Headquarters

Vancouver, British Columbia, Can

Founded

2009

BriaCell Therapeutics Corporation is listed in the Aircraft sector of the NASDAQ with ticker BCTX. The last closing price for BriaCell Therapeutics was $0.98. Over the last year, BriaCell Therapeutics shares have traded in a share price range of $ 0.4641 to $ 6.0994.

BriaCell Therapeutics currently has 18,384,661 shares outstanding. The market capitalization of BriaCell Therapeutics is $18.09 million. BriaCell Therapeutics has a price to earnings ratio (PE ratio) of -9.60.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.052	5.54371002132	0.938	1.42	0.6651	12040463	0.90501457	CS
4	0.2734	38.1523862685	0.7166	1.96	0.4641	14023186	0.69333875	CS
12	0.0702	7.63209393346	0.9198	1.96	0.4641	5095658	0.69737711	CS
26	-1.73	-63.6029411765	2.72	2.95	0.4641	2469919	0.71745025	CS
52	-4.91	-83.2203389831	5.9	6.0994	0.4641	1290703	0.85062979	CS
156	-6.26	-86.3448275862	7.25	12.47	0.4641	757651	3.96785953	CS
260	-3.25	-76.6509433962	4.24	12.47	0.4641	1119084	4.83408041	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LGMKLogicMark Inc	$ 0.165 (46.93%)	37.28M
PETZTDH Holdings Inc	$ 1.96 (44.22%)	4.46M
IVPInspire Veterinary Partners Inc	$ 0.3323 (25.11%)	8.64M
JNVRJanover Inc	$ 0.6599 (19.96%)	1
JWELJowell Global Ltd	$ 1.99 (16.37%)	591
LASELaser Photonics Corporation	$ 2.45 (-65.30%)	1.1M
TRVNTrevena Inc	$ 2.77 (-39.85%)	2.6k
BENFBeneficient	$ 1.45 (-23.28%)	210.75k
CETXCemtrex Inc	$ 1.631 (-18.86%)	274.07k
FRZAForza X1 Inc	$ 0.27 (-18.18%)	23.23k
LGMKLogicMark Inc	$ 0.165 (46.93%)	37.28M
IVPInspire Veterinary Partners Inc	$ 0.3323 (25.11%)	8.64M
TIGRUP Fintech Holding Ltd	$ 13.99 (12.91%)	4.9M
PETZTDH Holdings Inc	$ 1.96 (44.22%)	4.46M
ELABElevai Labs Inc	$ 0.1101 (1.94%)	3.25M